Daniel Carlat

Director, Prescription Project , The Pew Charitable Trusts

To reach this expert, please contact:

Amy E. Allen
Administrative Assistant


Dr. Daniel Carlat is the director of Pew's prescription project, which seeks to ensure transparency in physician-industry relationships and promotes policies to reduce or manage conflicts of interest that could affect patient care.

Before joining Pew, Carlat was a practicing psychiatrist and was president and CEO of Carlat Publishing LLC, which publishes non-industry supported continuing medical education newsletters for psychiatrists and other mental health practitioners.

Carlat is the author of numerous peer-reviewed articles and professional books in psychiatry, most notably The Psychiatric Interview: A Practical Guide, currently in its third edition and translated into several languages. In addition to his professional writing, Dr. Carlat has written about conflicts of interest for the New York Times, the New York Times Magazine, and Wired. His article for The New York Times Magazine, "Dr. Drug Rep", was selected for Harper Perennial’s Best Science Writing 2008 anthology. 

In 2010, he published his first book for a general audience, Unhinged: A Doctor’s Alarming Revelations about a Profession in Crisis. The book, which proposes solutions for reforming the  mental health care system in the U.S., has garnered significant media attention, including a July 2010 interview on NPR’s Fresh Air.

Dr. Carlat received his M.D. at the University of California, San Francisco, and completed his psychiatric  residency at Massachusetts General Hospital in Boston. He is associate clinical professor of psychiatry at Tufts School of Medicine.


Subscribe to This Feed

''Doctors Face New Scrutiny Over Gifts''

Media Coverage

"U.S. doctors are bracing for increased public scrutiny of the payments and gifts they receive from pharmaceutical and medical-device companies as a result of the new health law."


''Already Feeling the Heat''

Media Coverage

"The legislation requiring public disclosure of the financial relationships between healthcare vendors and physicians has been widely discussed in policy circles for years. Critics claimed payments for speaking, consulting, research or even the small trinkets and meals delivered during routine sales calls unduly influenced physician choices and inflated healthcare costs. To combat those effects, Congress required public reporting of those payments in a publicly accessible database. The legislation, labeled the Physician Payment Sunshine Act, was included in the 2010 healthcare reform law."


''Is Psychiatry Committing 'Professional Suicide'?''

Media Coverage

During a session at the American Psychiatric Association's annual meeting on conflicts of interest, experts delved into the link between psychiatry and the pharmaceutical industry. While several speakers at the session pointed out that other specialties are similarly entangled with industry, "everyone does it" is generally not a valid defense where conflicts of interest are concerned.


See More


Protecting the Integrity of Medical Education

We invite you to join us on Dec. 11 for a webinar presentation and discussion of the challenges involved in limiting industry marketing influence in medical education, hosted by The Pew Charitable Trusts in partnership* with the American Medical Student Association, Community Catalyst, and the National Physicians Alliance. More


Letter from Pew to CMS Regarding Physician Payments Sunshine Act

Issue Brief

Prescription project director Danny Carlat identifies issues with the Physician Payments Sunshine Act requiring further clarification and guidance. Addressing those would ensure that manufacturers can appropriately implement the final rule, and enable consumers to benefit from transparency reports published by the Centers for Medicare & Medicaid Services.


Written Statement of Record Regarding the Sunshine Act by Dr. Daniel J. Carlat of the Pew Health Group

Issue Brief

Dr. Daniel Carlat, Director of the Pew Prescription Project, appeared before the U.S. Senate Special Committee on Aging to testify about the importance of implementing the Physician Payments Sunshine Act as quickly as possible.